NCT01089270
Unknown
Not Applicable
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
ConditionsParkinson Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson Disease
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 80
- Locations
- 1
- Last Updated
- 16 years ago
Overview
Brief Summary
Parkinson Disease is one of the most common neurodegenerative illnesses. First degree relatives of Parkinson patient are in high risk for developing the disease. We will try to detect early changes in brain metabolism before the appearance of Parkinson symptoms.
Participants: first degree relatives of diagnosed Parkinson patients that carry a gene mutation in either LRRK2 or GBA genes.
The examination results will be given to the participants by a doctor from the neurology department.
Investigators
Eligibility Criteria
Inclusion Criteria
- •healthy first degree relatives of diagnosed Parkinson patients
Exclusion Criteria
- •patients unable to understand and sign an informed consent
- •people with psychiatric disorders or a history of major head trauma
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic CharacteristicsParkinson DiseaseNCT01089283Tel-Aviv Sourasky Medical Center80
Completed
Not Applicable
Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism SyndromesTau Distributions in Patients With Tauopathy Using APN-1607 PET ScanNCT04557865National Taiwan University Hospital68
Recruiting
Not Applicable
Non-invasive Detection of Volatile Metabolites in Parkinson's DiseaseParkinson DiseaseNCT06453226Imperial College London120
Unknown
Not Applicable
New Biomarkers in Parkinson's DiseaseParkinson DiseaseNCT05150158Neuromed IRCCS60
Completed
Not Applicable
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.Parkinson DiseaseNCT06156917IRCCS San Raffaele100